TY - JOUR
T1 - Thoracic aortic endograft explant
T2 - A single-center experience
AU - Kirkwood, Melissa L.
AU - Pochettino, Alberto
AU - Fairman, Ronald M.
AU - Jackson, Benjamin M.
AU - Woo, Edward Y.
AU - Wang, Grace J.
N1 - Copyright:
Copyright 2011 Elsevier B.V., All rights reserved.
PY - 2010/8
Y1 - 2010/8
N2 - Objectives: We report our experience following thoracic aortic endovascular repair (TEVAR) explant. Methods: A total of 500 TEVARs were performed from 1999 to 2009, with 4 requiring explant. Chart review was performed to identify the indications of explant, operative technique, and perioperative morbidity and mortality. Results: Indications of graft removal included device maldeployment, type I endoleak, aortoenteric fistula, and retrograde type A dissection necessitating aortic root replacement. Reconstruction was achieved with aortic homograft, Dacron, or explant of the proximal component with incorporation of the distal stent into the suture line. Mean follow-up was 13 months (0-50 months). Paraplegia and perioperative death occurred in 1 patient who underwent intraoperative conversion to open repair. There were no other major complications, and graft removal was achieved in all patients. Conclusions: Although rare, familiarity with TEVAR explant is imperative as it is increasingly performed for broader indications. Our limited data suggest that explant can be performed successfully albeit with morbidity.
AB - Objectives: We report our experience following thoracic aortic endovascular repair (TEVAR) explant. Methods: A total of 500 TEVARs were performed from 1999 to 2009, with 4 requiring explant. Chart review was performed to identify the indications of explant, operative technique, and perioperative morbidity and mortality. Results: Indications of graft removal included device maldeployment, type I endoleak, aortoenteric fistula, and retrograde type A dissection necessitating aortic root replacement. Reconstruction was achieved with aortic homograft, Dacron, or explant of the proximal component with incorporation of the distal stent into the suture line. Mean follow-up was 13 months (0-50 months). Paraplegia and perioperative death occurred in 1 patient who underwent intraoperative conversion to open repair. There were no other major complications, and graft removal was achieved in all patients. Conclusions: Although rare, familiarity with TEVAR explant is imperative as it is increasingly performed for broader indications. Our limited data suggest that explant can be performed successfully albeit with morbidity.
KW - TEVAR
KW - endograft explant
KW - thoracic aortic aneurysm
UR - http://www.scopus.com/inward/record.url?scp=77954941420&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=77954941420&partnerID=8YFLogxK
U2 - 10.1177/1538574410371525
DO - 10.1177/1538574410371525
M3 - Article
C2 - 20519282
AN - SCOPUS:77954941420
SN - 1538-5744
VL - 44
SP - 440
EP - 445
JO - Vascular and Endovascular Surgery
JF - Vascular and Endovascular Surgery
IS - 6
ER -